The COVID-19 pandemic has highlighted a need for non-invasive, remote approaches to patient care. Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics, met to discuss new ways to treat brain diseases at home. Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home.
Episode 29: Low Back Pain – Part 1 Dr. Ramchandani discusses the basics of low back pain. Bonus: some good news about COVID-19 research.
Episode 28: Prostate Cancer Dr. Ramchandani discusses the incidence and death rate of Prostate cancer. What you can do to prevent it? How to stay healthy, active, and eat right. Also, the good news of the week! Thank you for listening.
What does it really take to get that big idea to market? Entrepreneurs Eric Grigsby, MD, MBA, CEO and Founder of Neurovations, and David Caraway, MD PhD, CMO from Nevro discussed some of the fundamentals to launch a new idea.
CEO and Founder of Neurovations, Dr. Eric Grigsby, and Co-founder and Director of Research at Millennium Pain Center, Dr. Ricardo Vallejo joined up for a deep dive into how a hypothesis can change the way we think about SCS therapies and optimizing outcomes. Dr. Vallejo unpacked the questions necessary to get to a truer understanding […]
Rocca Family Vineyards hosts mobile COVID-19 testing in the parking lot.
N3 Laboratories is proud to offer Serology (Antibody) testing for COVID-19
HF10® is a next-generation spinal cord stimulation (SCS) system offering a wide range of benefits: -HF10 has demonstrated significant relief for both back and leg pain.¹ -HF10 can be left on 24 hours a day, 7 days a week because it calms the nerves while allowing you to feel everything you should. -HF10 isn’t addictive […]
CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff met for an in-depth discussion on the activation of neuroimmune reflexes by Vagus Nerve Stimulation which reduced disease activity in a proof-of-concept study in Rheumatoid Arthritis. Watch the Video
CEO and Founder of Neurovations, Dr. Eric Grigsby joined Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.
The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal ziconotide.
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.